annual CFI:
$185.01M+$113.17M(+157.53%)Summary
- As of today (June 28, 2025), BEAM annual cash flow from investing activities is $185.01 million, with the most recent change of +$113.17 million (+157.53%) on December 31, 2024.
- During the last 3 years, BEAM annual CFI has risen by +$479.15 million (+162.90%).
- BEAM annual CFI is now at all-time high.
Performance
BEAM Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$125.09M-$251.37M(-199.06%)Summary
- As of today (June 28, 2025), BEAM quarterly cash flow from investing activities is -$125.09 million, with the most recent change of -$251.37 million (-199.06%) on March 31, 2025.
- Over the past year, BEAM quarterly CFI has dropped by -$71.63 million (-133.97%).
- BEAM quarterly CFI is now -199.06% below its all-time high of $126.28 million, reached on December 31, 2024.
Performance
BEAM quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$113.38M-$71.63M(-38.71%)Summary
- As of today (June 28, 2025), BEAM TTM cash flow from investing activities is $113.38 million, with the most recent change of -$71.63 million (-38.71%) on March 31, 2025.
- Over the past year, BEAM TTM CFI has increased by +$120.46 million (+1702.57%).
- BEAM TTM CFI is now -38.71% below its all-time high of $185.01 million, reached on December 31, 2024.
Performance
BEAM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BEAM Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +157.5% | -134.0% | +1702.6% |
3 y3 years | +162.9% | +76.7% | +120.5% |
5 y5 years | +377.5% | -62.9% | +180.4% |
BEAM Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +140.1% | -199.1% | +76.7% | -38.7% | +117.4% |
5 y | 5-year | at high | +140.1% | -199.1% | +76.7% | -38.7% | +117.4% |
alltime | all time | at high | +140.1% | -199.1% | +76.7% | -38.7% | +117.4% |
BEAM Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$125.09M(-199.1%) | $113.38M(-38.7%) |
Dec 2024 | $185.01M(+157.5%) | $126.28M(+411.3%) | $185.01M(+18.0%) |
Sep 2024 | - | $24.70M(-71.8%) | $156.83M(+28.7%) |
Jun 2024 | - | $87.49M(-263.6%) | $121.90M(-1822.9%) |
Mar 2024 | - | -$53.46M(-154.5%) | -$7.08M(-109.8%) |
Dec 2023 | $71.84M(-115.6%) | $98.10M(-1058.9%) | $71.84M(-17.6%) |
Sep 2023 | - | -$10.23M(-75.3%) | $87.18M(+42.4%) |
Jun 2023 | - | -$41.48M(-263.0%) | $61.24M(-39.6%) |
Mar 2023 | - | $25.45M(-77.6%) | $101.45M(-122.0%) |
Dec 2022 | -$461.34M(+56.8%) | $113.44M(-413.6%) | -$461.34M(-29.3%) |
Sep 2022 | - | -$36.17M(+2766.4%) | -$652.27M(+20.8%) |
Jun 2022 | - | -$1.26M(-99.8%) | -$539.98M(-2.2%) |
Mar 2022 | - | -$537.34M(+593.4%) | -$551.86M(+87.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$294.14M(+193.8%) | -$77.50M(-201.8%) | -$294.14M(-1.3%) |
Sep 2021 | - | $76.11M(-679.4%) | -$298.07M(-12.1%) |
Jun 2021 | - | -$13.14M(-95.3%) | -$338.96M(+11.9%) |
Mar 2021 | - | -$279.63M(+243.4%) | -$302.96M(+202.6%) |
Dec 2020 | -$100.12M(+50.2%) | -$81.43M(-331.1%) | -$100.12M(+4585.2%) |
Sep 2020 | - | $35.23M(+54.0%) | -$2.14M(-90.8%) |
Jun 2020 | - | $22.87M(-129.8%) | -$23.15M(-83.6%) |
Mar 2020 | - | -$76.79M(-563.7%) | -$141.10M(+111.7%) |
Dec 2019 | -$66.66M(+396.6%) | $16.56M(+16.5%) | -$66.66M(-19.9%) |
Sep 2019 | - | $14.21M(-114.9%) | -$83.22M(-14.6%) |
Jun 2019 | - | -$95.08M(+3939.0%) | -$97.43M(+4039.0%) |
Mar 2019 | - | -$2.35M | -$2.35M |
Dec 2018 | -$13.42M | - | - |
FAQ
- What is Beam Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Beam Therapeutics?
- What is Beam Therapeutics annual CFI year-on-year change?
- What is Beam Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Beam Therapeutics?
- What is Beam Therapeutics quarterly CFI year-on-year change?
- What is Beam Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Beam Therapeutics?
- What is Beam Therapeutics TTM CFI year-on-year change?
What is Beam Therapeutics annual cash flow from investing activities?
The current annual CFI of BEAM is $185.01M
What is the all time high annual CFI for Beam Therapeutics?
Beam Therapeutics all-time high annual cash flow from investing activities is $185.01M
What is Beam Therapeutics annual CFI year-on-year change?
Over the past year, BEAM annual cash flow from investing activities has changed by +$113.17M (+157.53%)
What is Beam Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of BEAM is -$125.09M
What is the all time high quarterly CFI for Beam Therapeutics?
Beam Therapeutics all-time high quarterly cash flow from investing activities is $126.28M
What is Beam Therapeutics quarterly CFI year-on-year change?
Over the past year, BEAM quarterly cash flow from investing activities has changed by -$71.63M (-133.97%)
What is Beam Therapeutics TTM cash flow from investing activities?
The current TTM CFI of BEAM is $113.38M
What is the all time high TTM CFI for Beam Therapeutics?
Beam Therapeutics all-time high TTM cash flow from investing activities is $185.01M
What is Beam Therapeutics TTM CFI year-on-year change?
Over the past year, BEAM TTM cash flow from investing activities has changed by +$120.46M (+1702.57%)